Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Normal Renal Function”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00999336
What this trial is testing

Determine the Pharmacokinetics, Pharmacodynamics, and Tolerabiltiy of Betrixaban in Patients With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Impairment
Portola Pharmaceuticals 32
Early research (Phase 1)Study completedNCT03660241
What this trial is testing

A Renal Impairment Study for PF-04965842

Who this might be right for
Renal Impairment
Pfizer 23
Early research (Phase 1)Study completedNCT06657560
What this trial is testing

Pharmacokinetics, Dialysability and Safety of HRS-9231 in Healthy Volunteers and in Patients With Impaired Renal Function

Who this might be right for
Contrast-Enhanced Magnetic Resonance Imaging Detection
Shanghai Shengdi Pharmaceutical Co., Ltd 41
Post-approval studies (Phase 4)Study completedNCT01491113
What this trial is testing

Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients

Who this might be right for
Healthy SubjectsRenal Impairments
UCB Pharma 30
Early research (Phase 1)Study completedNCT02436447
What this trial is testing

Study Investigating the Safety and Pharmacokinetics of Repeat-dose Intravenous Infusion of MTP-131 in Subjects With Impaired Renal Function

Who this might be right for
Normal and Impaired Renal Function
Stealth BioTherapeutics Inc. 23
Early research (Phase 1)Study completedNCT01569815
What this trial is testing

Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function

Who this might be right for
Mild and Moderate Renal Impairment
Novartis Pharmaceuticals 32
Early research (Phase 1)Study completedNCT00833716
What this trial is testing

Effect of Renal Impairment on the Pharmacokinetics of NN9535

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Renal Impairment
Novo Nordisk A/S 62
Early research (Phase 1)Study completedNCT01393964
What this trial is testing

Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 35
Early research (Phase 1)Study completedNCT06496217
What this trial is testing

Safety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function

Who this might be right for
Renal Impairment
MBX Biosciences 25
Early research (Phase 1)Study completedNCT02275156
What this trial is testing

Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab

Who this might be right for
HyperlipidemiaMixed Dyslipidemia
Amgen 18
Early research (Phase 1)Study completedNCT00472836
What this trial is testing

Study Examining The Effect Of Renal Impairment On Safety, Toleration And How The Body Processes An Experimental Drug

Who this might be right for
Obesity
Pfizer 17
Early research (Phase 1)UnknownNCT05328843
What this trial is testing

Study to Evaluate the Pharmacokinetic Characteristics of Pegylated Exenatide Injection (PB-119) in Subjects With Different Degrees of Renal Insufficiency and Matched Subjects With Normal Renal Function

Who this might be right for
Type2Diabetes
PegBio Co., Ltd. 24
Early research (Phase 1)Study completedNCT00938158
What this trial is testing

The Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 75
Early research (Phase 1)Study completedNCT03442725
What this trial is testing

Study to Compare a Dose of Telotristat Etiprate in Subjects With Renal Impairment With Matched Subjects With Normal Renal Function

Who this might be right for
Renal Impairment
Ipsen 16
Early research (Phase 1)Study completedNCT04446507
What this trial is testing

A Pharmacokinetic Study of Saroglitazar Magnesium in Subjects with Severe Renal Impairment and Normal Renal Function

Who this might be right for
Renal Impairment
Zydus Therapeutics Inc. 32
Early research (Phase 1)Study completedNCT05895812
What this trial is testing

A Study in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function

Who this might be right for
Subjects With Renal ImpairmentHealthy Subjects
Shanghai Vinnerna Biosciences Co., Ltd. 24
Early research (Phase 1)Study completedNCT02402452
What this trial is testing

Pharmacokinetics of Voxilaprevir in Adults With Normal Renal Function and Severe Renal Impairment

Who this might be right for
HCV Infection
Gilead Sciences 20
Early research (Phase 1)Study completedNCT02674581
What this trial is testing

The Pharmacokinetics and Safety of BMS-663068 Administered in Subjects With Normal Renal Function and With Mild, Moderate, Severe and End Stage Renal Dysfunction (ESRD)

Who this might be right for
HIV Infections
ViiV Healthcare 30
Early research (Phase 1)Study completedNCT01478399
What this trial is testing

Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function

Who this might be right for
Diabetes Mellitus, Type 2
PhaseBio Pharmaceuticals Inc. 16
Early research (Phase 1)Study completedNCT01309438
What this trial is testing

Erythromycin and Rivaroxaban in Study Participants With Normal and Reduced Kidney Function

Who this might be right for
HealthyRenal Insufficiency
Janssen Research & Development, LLC 29
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation